14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LXRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Wednesday for Lexicon Pharmaceuticals
(Updated on Apr 24, 2024)

Sell candidate since Mar 21, 2024 Loss -33.61% PDF

The Lexicon Pharmaceuticals stock price fell by -0.621% on the last day (Wednesday, 24th Apr 2024) from $1.61 to $1.60. During the last trading day the stock fluctuated 4.49% from a day low at $1.56 to a day high of $1.63. The price has fallen in 6 of the last 10 days and is down by -20.79% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $2.82 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.24 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -14.68% during the next 3 months and, with a 90% probability hold a price between $1.05 and $2.70 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LXRX Signals & Forecast

There are few to no technical positive signals at the moment. The Lexicon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.65 and $2.13. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -55.31%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Lexicon Pharmaceuticals stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0700 between high and low, or 4.49%. For the last week, the stock has had daily average volatility of 7.88%.

Lexicon Pharmaceuticals is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LXRX) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Lexicon Pharmaceuticals to open at $1.60, and during the day (based on 14 day Average True Range), to move between $1.44 and $1.76, which gives a possible trading interval of +/-$0.165 (+/-10.30%) up or down from last closing price. If Lexicon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 20.60% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $1.78, some $0.180 (11.25%) from the current price of $1.60, our system finds the risk reward not very attractive.

Is Lexicon Pharmaceuticals stock A Buy?

Lexicon Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.209 Strong Sell Candidate Unchanged

Predicted Opening Price for Lexicon Pharmaceuticals of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$1.60 ( 0.208%) $1.60

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LXRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.67 4.17 %
R2 1.64 2.50 %
R1 1.62 1.46 %
Current price: 1.60
Support S1 1.57 -1.88 %
S2 1.55 -2.91 %
S3 1.53 -4.58 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.98 23.75 %
R2 1.87 16.88 %
R1 1.78 11.25 %
Current price 1.60
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Lexicon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Lexicon Pharmaceuticals is LXRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lexicon Pharmaceuticals Stock.

What's the current price of Lexicon Pharmaceuticals Stock?
As of the end of day on the Apr 24, 2024, the price of an Lexicon Pharmaceuticals (LXRX) share was $1.60.

What is the 52-week high and low for Lexicon Pharmaceuticals Stock?
The 52-week high for Lexicon Pharmaceuticals Stock is $3.79 and the 52-week low is $0.92.

What is the market capitalization of Lexicon Pharmaceuticals Stock?
As of the Apr 24, 2024, the market capitalization of Lexicon Pharmaceuticals is 393.979M.

When is the next earnings date for Lexicon Pharmaceuticals?
The upcoming earnings date for Lexicon Pharmaceuticals is May 07, 2024.
Click to get the best stock tips daily for free!

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan... LXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT